Cyclosporin a induces erythroid differentiation of K562 cells through p38 MAPK and ERK pathways

American Journal of Hematology

Volumn 72, Issue 1, 2003, Pages 67-69

  Sawafuji, Kanoko ^a   Miyakawa, Yoshitaka ^a   Kizaki, Masahiro ^a   Ikeda, Yasuo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

C myb; Cyclosporin A; Differentiation; Erythroid; Hemoglobin

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLOSPORIN A; ERYTHROPOIETIN; HEMOGLOBIN; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; ERYTHROID CELL; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

BUTADIENES; CELL DIFFERENTIATION; CYCLOSPORINE; ENZYME ACTIVATION; ENZYME INHIBITORS; ERYTHROID PROGENITOR CELLS; HEMOGLOBINS; HUMANS; IMIDAZOLES; K562 CELLS; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; NITRILES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES;

EID: 0037220351     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10245     Document Type: Article

References (8)

1. Wu H, Liu X, Jaenisch R, Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995;83:59-67.
2. Andrews NC, Orkin SH. Transcriptional control of erythropoiesis. Curr Opin Hematol 1994;1:119-124.
3. Rausch O, Marshall CJ. Tyrosine 763 of the murine granulocyte colony stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway. Mol Cell Biol 1997;17:1170-1179.
4. Nagata Y, Takahashi N, Davis RJ, Todokoro K. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 1998;92:1859-1869.
5. Kiani A, Rao A, Aramburu J. Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 2000;12:359-372.
6. Witt O, Sand K, Pekrun A. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood 2000;95:2391-2396.
7. Park JI, Choi HS, Jeong JS, Han JY, Kim IH. Involvement of p38 kinase in hydroxyurea-induced differentiation of K562 cells. Cell Growth Differ 2001;12:481-486.
8. 2+/calmodulin-dependent and -independent down-regulation of c-myb mRNA levels in erythropoietin-responsive murine erythroleukemia cells. The role of calcineurin. J Biol Chem 1996;271:13484-13490.